派格生物医药-B（02565）于2026年3月4日公告，截至2026年2月28日，公司已发行H股股数为284,300,339股，非上市股份为106,791,193股，两者均与上月底持平，总注册股本维持在391,091,532股，未见新增发行或回购注销情况。
公告显示，公司于报告期内并无股份期权及可换股票据的新增或变动，也不存在任何购回及注销活动。根据公告披露，公司确认截至2月28日持续满足香港联交所相关上市规则规定的公众持股量要求。
该份月报由联合公司秘书黄一峰签署。根据公告信息，公司整体股本结构在2月末保持稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.